ArticleCell death & disease2024

CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity.

Chan-Chuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.